NCT00325390
- Conditions
- NSTEACS, Platelet Aggregation Inhibitors
- Locations
-
- Sanofi-Aventis Tokyo, Japan
Clinical trial condition
Explore clinical trials studying NSTEACS. Study availability and eligibility vary by location and protocol.
NCT00325390